KMID : 0358420140570020144
|
|
Korean Journal of Obstetrics and Gynecology 2014 Volume.57 No. 2 p.144 ~ p.150
|
|
Comparison of estrogen receptor-¥á, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids
|
|
Kim Eun-Hee
Kim Joo-Young Lee Yoon-Hee Chong Gun-Oh Hong Dae-Gy Park Ji-Young
|
|
Abstract
|
|
|
Objective: This study was aimed to compare immunohistochemical expression of estrogen receptor (ER)-¥á, progesterone receptor (PR), and calponin in gonadotrophin-releasing hormone agonist (GnRH-a)-sensitive and -resistant uterine fibroids.
Methods: We collected data retrospectively. The sensitive group consisted of women who had reduction in uterine volume greater than 40% following GnRH-a treatment. Uterine volume was either reduced by less than 10%, or was increased in the resistant group. A tissue microarray was constructed using formalin-fixed, paraffin-embedded tissues, 31 and 26 patients for the sensitive and resistant groups, respectively. Tissue sections were immunostained with antibodies against ER-¥á, PR, and calponin. The intensity and area of the immunohistochemical reactions were evaluated using a semi-quantitative scoring system. The Mann-Whitney U-test, Fisher¡¯s exact test, and Spearman¡¯s rank correlation test were used for analysis of data.
Results: PR (P = 0.04) and calponin (P = 0.03) showed a significantly higher staining intensity in the resistant group than in the sensitive group. Both groups showed comparable expression of ER-¥á (P = 0.23). In correlation analysis between changes in uterine volume after GnRH-a therapy and clinicopathological factors, the immunohistochemical intensity of PR (P = 0.04) and calponin (P = 0.03) was significantly correlated with changes in uterine volume.
Conclusion: This study shows that GnRH-a resistance of uterine fibroids is not related to ER-¥á content, but the expression of PR and calponin is related with GnRH-a resistance.
|
|
KEYWORD
|
|
Calponin, Estrogen receptor, Gonadotropin-releasing hormone agonist, Leiomyoma, Progesterone receptor
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|